首页> 外文期刊>Journal of Surgical Oncology >Prevention of lymphocele in female pelvic lymphadenectomy by a collagen patch coated with the human coagulation factors: A pilot study
【24h】

Prevention of lymphocele in female pelvic lymphadenectomy by a collagen patch coated with the human coagulation factors: A pilot study

机译:涂有人体凝血因子的胶原蛋白片预防女性盆腔淋巴结清扫术的淋巴膨大:一项初步研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Objectives The prevention of lymphoceles was tested using collagen patch coated with the human coagulation factors (TachoSil) on 58 consecutive patients with endometrial cancer who had undergone hysterectomy and pelvic lymphadenectomy (PL). Methods Patients were randomized in two groups: standard technique plus TachoSil (30 patients, group 1) and standard technique only (28, group 2). All surgical parameters were collected and patients underwent ultrasound examination on postoperative days 7, 14, and 28. The main outcome measures were: the development of symptomatic or asymptomatic lymphoceles, the need for further surgical intervention, as adverse effect of surgery and the drainage volume and duration. Results Same number of lymph nodes in both groups was removed; group 1 showed a lower drainage volume. Lymphoceles developed in 7 patients in group 1 and 16 in group 2, but only 3 were symptomatic in group 1 and 9 symptomatic in group 2, with statistical difference. Percutaneous drainage proved necessary in five cases: only one was in group 1 and four in group 2. Conclusions Intraoperative application of TachoSil reduced rate of postoperative lymphocysts after PL, and it seems to provide a useful additional treatment option for reducing drainage volume and preventing lymphocele development after PL.
机译:背景与目的在58例接受子宫切除术和盆腔淋巴结清扫术(PL)的子宫内膜癌连续患者中,使用涂有人凝血因子(TachoSil)的胶原蛋白贴剂测试了预防淋巴结肿大的方法。方法将患者随机分为两组:标准技术加TachoSil(30例,第1组)和仅标准技术(28,第2组)。收集所有手术参数,并在术后第7、14和28天对患者进行超声检查。主要结局指标包括:有症状或无症状的淋巴结肿大,需要进一步的手术干预,手术的不良反应和引流量和持续时间。结果两组患者的淋巴结数目相同。第一组显示较低的引流量。第1组7例患者出现淋巴囊肿,第2组16例出现淋巴囊肿,但第1组仅有3例有症状,第2组有9例有症状,统计学差异。经证实有5例行经皮引流:第1组仅1例,第2组4例。结论术中应用TachoSil可以降低PL术后的术后淋巴囊肿发生率,这似乎为减少引流量和预防淋巴结肿大提供了有用的其他治疗选择。 PL之后的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号